COAG
Hemab Therapeutics Holdings, Inc.
39.33
+0.56 (+1.44%)
52w low 23.00
55.42 high
50.4% of range
Financial Analysis
| (USD) | Dec 24 | Dec 25 | Trend |
|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | |
| Operating Expenses | 50.38M | 70.12M | |
| R&D | 41.41M | 59.63M | |
| SG&A | 8.97M | 10.49M | |
| Operating Income | -50.38M | -70.12M | |
| EBITDA | -50.13M | -69.81M | |
| Pretax Income | -48.52M | -64.14M | |
| Income Tax | 185.00K | -227.00K | |
| Net Income | -48.71M | -63.91M | |
| EPS Diluted | -1.77 | -2.33 | |
| Diluted Shares | 27.44M | 27.44M |
Revenue CAGR
--
Net Income CAGR
--
EPS CAGR
--
FCF CAGR
--
Revenue YoY
--